Received: 23 March 2021
Accepted: 29 June 2021
First Online: 11 July 2021
: Ethics approval was obtained from the Health Research Ethics Board of Alberta-Cancer Committee (HREBA.CC-18-0590). The introductory cover letter and survey were reviewed and approved by the ethics committee. The ethics committee approved a waiver of consent for this minimal risk study. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.